
    
      This is an open-label, multi-center, exploratory study to estimate the effect of intranasal
      administration of QR-010 on the nasal mucosa in the restoration of CFTR function, as measured
      by nasal potential difference (NPD), in the nasal epithelium of adult subjects with CF who
      are homozygous or compound heterozygous for the Î”F508 CFTR mutation.
    
  